January 3, 2019 Synthetic Biologics Announces First Two Patients Enrolled in Phase 2b Investigator-Sponsored
November 21, 2018 Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
November 8, 2018 Synthetic Biologics Reports Third Quarter 2018 Operational Highlights and Financial Results
October 30, 2018 Synthetic Biologics to Report Third Quarter 2018 Operational Highlights and Financial Results on November 8, 2018
September 6, 2018 Synthetic Biologics Announces Agreement with Cedars-Sinai Medical Center for an Investigator-Sponsored Clinical Study of SYN-010, for the Treatment of IBS-C
August 30, 2018 Synthetic Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 8, 2018 Synthetic Biologics Reports Second Quarter 2018 Operational Highlights and Financial Results
